View More View Less
  • 1 Budai Irgalmasrendi Kórház, Budapest
  • | 2 Uzsoki Utcai Kórház, Budapest, Uzsoki u. 29–41., 1145
Open access

Absztrakt:

A hidroxiklorokin egy immunmodulátor szer, amelyet elsősorban malária, lupus erythematosus és rheumatoid arthritis esetén alkalmaznak. A szerzők összefoglalják ennek a készítménynek a lehetséges proarrhythmiás hatását és ennek kapcsán a gyógyszer indukálta hosszú-QT-szindróma felismerésének legfontosabb jeleit. A jelen összefoglaló aktualitását a COVID–19-járványban a hidroxiklorokin (jelenleg evidencia nélküli) gyakoribb alkalmazása adja. Orv Hetil. 2020; 161(17): 689–691.

  • 1

    Jervell A, Lange-Nielsen F. Congenital deaf-mutation, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J. 1957; 54: 59–68.

  • 2

    El-Sherif N, Turitto G, Boutjdir M. Acquired long QT syndrome and electrophysiology of torsade de pointes. Arrhythm Electrophysiol Rev. 2019; 8: 122–130.

  • 3

    Fazekas T, Liszkai G. Clinical proarrhythmias induced by anti-arrhythmic drugs, non-cardiovascular agents and implantable cardioverter-defibrillators. [Antiarrhythmiás és nem szív-érrendszeri gyógyszerek, valamint beültethető cardioverter defibrillátorok által előidézett klinikai pro-arrhythmiák.] Orv Hetil. 2002; 143: 61–69. [Hungarian]

  • 4

    Topilski J, Rogowski O, Rosso R, et al. The morphology of the QT interval predicts torsade de pointes during acquired bradyarrhythmias. J Am Coll Cardiol. 2007; 49: 320–328.

  • 5

    World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance. WHO, Geneva, 13 March 2020. Available from: https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected [accessed: 30 March 2020].

  • 6

    Wang M, Ca OR, Zhang L, et al. Remdesevir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCov) in vitro. Cell Research 2020; 30: 269–271.

  • 7

    Paulussen AD, Gilissen RA, Amstrong M, et al. Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1 and KCNE2 in drug-induced long QT syndrome patients. J Mol Med. 2004: 82: 182–188.

  • 8

    Tomcsányi J, Tomcsányi K. ECG pearl: acquired long QT syndrome. [EKG-gyöngyszem: szerzett hosszú-QT-szindróma. Orv Hetil. 2018; 159: 1607–1610. [Hungarian]

  • 9

    Cho Y, Lim HS, Chung D, et al. Risk evaluation of azithromycin-induced QT prolongation in real-world practice. Biomed Res Int. 2018; 2018: 1574806.

  • 10

    Jordan P, Brookes JG, Nikolic G, et al. Hydroxychloroquine overdose: toxicokinetics and management. J Toxicol Clin Toxicol. 1999; 37: 861–864.

  • 11

    O’Laughlin JP, Mehta PH, Wong BC. Life threatening severe QTc prolongation in patient with systemic lupus erythematosus due to hydroxychloroquine. Case Rep Cardiol. 2016; 2016: 4626279.

  • 12

    Morgan ND, Patel SV, Dvorkina O. Suspected hydoxychloroquine-associated QT-interval prolongation in a patient with systemic lupus erythematosus. J Clin Rheum 2013; 19: 286–288.

  • 13

    Chen CY, Wang FL, Lin CC. Chronic hydroxychloroquine use associated with QT prolongation and refractory ventricular arrhythmia. Clin Toxicol. 2006; 44: 173–175.

  • 14

    Drew JB, Ackerman MJ, Funk M, et al. Prevention of torsade de pointes in hospital settings. Scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol. 2010; 55: 934–948.

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Jan 2021 0 31 44
Feb 2021 0 25 47
Mar 2021 0 40 75
Apr 2021 0 25 66
May 2021 0 36 60
Jun 2021 0 15 27
Jul 2021 0 0 0